T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
- 1 January 1985
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 134 (1), 369-374
- https://doi.org/10.4049/jimmunol.134.1.369
Abstract
The effects of a preparation containing partially purified, EL4-derived B cell growth factor(s) (BCGF) on B cell growth and proliferation have been examined by using B lymphocyte subpopulations separated on the basis of size. BCGF was found to maintain and enhance proliferation of a significant proportion of large activated B cells. In contrast, small resting B cells required the presence of BCGF and a second stimulus such as anti-IgM antibody (anti-mu) to be induced to proliferate. This disparity was not due to a lack of an effect of BCGF on small resting B cells. A factor contained within the partially purified EL4 supernatant produced time-dependent increases in cell size and RNA content in all subpopulations. These effects were independent of possible effects due to contaminating lymphokines such as interleukin 2 (IL 2), concanavalin A (Con A), and phorbol myristate acetate (PMA). Nonmitogenic doses of lipopolysaccharide (LPS) failed to show similar effects. Our data suggest that B cells at all levels of in vivo activation are responsive to stimulation by a growth factor present in EL4 supernatant, as manifested by cell growth and RNA synthesis. This activity has not previously been described for BCGF preparations. However, because the partially purified, EL4-derived supernatant used as BCGF in these studies has not been purified to homogeneity, we cannot conclude whether the factors that induce resting B cells to increase in size are the same as the growth factors that synergize with anti-mu to induce B cell proliferation or that maintain the proliferation of activated B cells.This publication has 17 references indexed in Scilit:
- Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.The Journal of Experimental Medicine, 1983
- Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.The Journal of Immunology, 1983
- B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor.Proceedings of the National Academy of Sciences, 1982
- Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor.The Journal of Experimental Medicine, 1982
- Display and analysis of cell size distributions with a Coulter Counter interfaced to an Apple II microcomputerJournal of Immunological Methods, 1982
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.The Journal of Experimental Medicine, 1981
- Thymoma production of T cell growth factor (Interleukin 2).The Journal of Immunology, 1980
- Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.The Journal of Immunology, 1980
- Lymphocyte stimulation: a rapid multiparameter analysis.Proceedings of the National Academy of Sciences, 1976